Differential effects of taxol on two human cancer cell lines

Oncology Research

Volumn 9, Issue 5, 1997, Pages 237-248

  Banerjee, Srabani ^a   Fallis, Alex G ^b   Brown, David L ^b  

^a Department of Biology ^*  (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Apoptosis; Cancer cells; Microtubules; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; DNA FRAGMENT; PACLITAXEL;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL STRAIN HT29; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MELANOMA; METABOLISM; MICROTUBULE; PATHOLOGY; SKIN TUMOR;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; DNA FRAGMENTATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, AGAR GEL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HT29 CELLS; HUMANS; MELANOMA; MICROTUBULES; PACLITAXEL; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030634825     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Rowinsky, E. K.; Tucker, R. W.; Burke, P. J.; Ettinger, D. S.; Donehower, R. C. Phase l and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res. 49:4640-4647; 1989.
2. McGuire, W. P.; Rowinsky, E. K.; Rosenshine, N. B.; Grumbine, F. C.; Ettinger, D. S.; Armstrong, D. K.; Donehower, R. C. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann. Intern. Med. 111:273-279; 1989.
3. Holmes, F. A.; Walters, R. S.; Theriault, A. T.; Forman, A. D.; Newton, L. K.; Raber, M. N.; Buzdar, A. C.; Frye, D. K.; Hortobagyi, G. N. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl. Cancer Inst. 83:1797-1805:1991.
4. Etlinger, D. S. Overview of paclitaxel (taxol) in advanced lung cancer. Semin. Oncol. 20:46-49; 1993.
5. Forastiere, A. A. Use of paclitaxel (taxol) in squamous cell carcinoma of the head and neck. Semin. Oncol. 20:56-60; 1993.
6. Einzig, A. I.; Wiernik, P. H. Melanoma. In: McGuire, W. P.; Rowinsky, E. K., eds. Paclitaxel in cancer treatment. New York: Marcel Dekker, Inc.; 1995:321-327.
7. Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggon, P.; McPhail, A. T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93:2325-2327; 1971.
8. Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of microtubule assembly in vitro by taxol. Nature 277:665-667; 1979.
9. Schiff, P. B.; Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sei. USA 77:15611565;1980.
10. Rao, S.; Krauss, N. E.; Heerding, J. M.; Swindells, C. S.; Ringel, I.; Orr, G. A.; Horwitz, S. B. 3'-(p-azidobenzamido) taxol photolabels the N-terminal 31 amino acids of 0-tubulin. J. Biol. Chem. 269:3132-3134; 1994.
11. Nogales, E.; Wolf, S. G.; Khan, I. A.; Luduena, R. F.; Downing, K. H. Structure of tubulin at 6.5 A and location of the taxol-binding site. Nature 375:424-427; 1995.
12. Lee, L. F.; Schuerer-Maly, C. C.; Lofquist, A. K.; van Haaften-Day, C.; Ting, J. P. Y.; White, C. M.; Martin, B. K.; Haskill, J. S. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer. Cancer Res. 56:1303-1308; 1996.
13. Bogdon, C.; Ding, A. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J. Leukoc. Biol. 52: 119-121; 1992.
14. Ding, A.; Sanchez, E.; Nathan, C. F. Taxol shares the ability of bacterial lipopolysaccharide to induce tyrosine phosphorylation of microtubule-associated protein kinases. J. Immunol. 151:5596-5602; 1993.
15. Galli, A.; DeFlice, L. J. Inactivation of L-type Ca channels in embryonic chick ventricle cells: Dependence on the cytoskeletal agents colchicine and taxol. Biophys. J. 67:2296-2304; 1994.
16. Cameron, M. R.; Caudle, M. R.; Sullivan, W. R., Jr.; Peluso, J. J.; Wimalasena, J. The steroidogenic and morphological effects of paclitaxel on cultured ovarian cancer cells. Oncol. Res. 7:145-156; 1995.
17. Runowicz, C. D.; Weirnik, P. H.; Einzig, A. I.; Goldberg, G. L.; Horwitz, S. B. Taxol in ovarian cancer. Cancer 71:15911596;1993.
18. Nicolaou, K. C.; Yang, Z.; Liu J. J.; Ueno, H.; Nantermet, P. G.; Guy, R. K.; Claiborne, C. F.; Renaud, J.; Couladouros, E. A.; Paulvannan, K.; Sorensen, E. J. Total synthesis of taxol. Nature 367:630-634; 1994.
19. Holton, R. A.; Somoza, C.; Kim, H. B. First total synthesis of taxol. 1. Functionalization of the B ring. J. Am. Chem. Soc. 116:1597-1598; 1994.
20. Holton, R. A.; Kim, H. B.; Somoza, C. First total synthesis of taxol. 2. Completion of C and D rings. J. Am. Chem. Soc. 116:1599-1600; 1994.
21. Lu, V. F.; Fallis, A. G. Synthetic approaches to tricyclic taxoid skeletons. Can. J. Chem. 73:2239-2252; 1995.
22. Lu, Y. F.; Harwig, C. W.; Fallis, A. G. Taxamycins: A new enediyne family with synthetic and biological potential. Can. J. Chem. 73:2253-2262; 1995.
23. Vaughn, D. J.; Haller, D. G. Introduction: Recent advances in colorectal cancer. Semin. Oncol. 22:415-417; 1995.
24. Slominski, A.; Ross, J.; Mihm, M. C. Cutaneous melanoma: Pathology, relevant prognostic indicators and progression. Br. Med. Bull. 51:548-569; 1995.
25. Falconer, M. M.; Vielkind, U.; Brown, D. L. Establishment of a stable, acetylated microtubule bundle during neuronal commitment. Cell Motil. Cytoskel. 12:169-180; 1989.
26. Skehan, P.; Storeng, R.; Scudeiro, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotxicity assay for anti-cancer drug screening. J. Natl. Cancer Inst. 82:11071112; 1990.
27. Ray, S.; Ponnathpur, V.; Huang, Y.; Yang, C.; Mahoney, M. E.; Ibrado, A. M. l-jS-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: Improved method for detection of internucleosomal DNA fragmentation. Cancer Chemother. Pharmacol. 34:365-371; 1994.
28. Garcia, P.; Braguer, D.; Carles, G.; Khyari, S. E.; Barra, Y.; de Inès, C.; Barasoain, I.; Briand, C. Comparative effects of taxol and taxotere on two different human carcinoma cell lines. Cancer Chemother. Pharmacol. 34:335-343; 1994.
29. Jordan, M. A.; Toso, R. J.; Thrower, D.; Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl. Acad. Sei. USA 90: 9552-9556;1993.
30. Rowinsky, E. K.; Donehower, R. C.; Jones, R. J.; Tucker, R. W. Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res. 48:4093-4100; 1988.
31. Roberts, J. R.; Rowinsky, E. K.; Donehower, R. C.; Robertson, J.; Allison, D. C. Demonstration of the cell cycle positions of taxol-induced asters and bundles by sequential measurements of tubulin immunofluorescence, DNA content, and autoradiographic labeling of taxol-sensitive and -resistant cells. J. Histochem. Cytochem. 37:1659-1665; 1989.
32. Roberts, J. R.; Allison, D. C.; Donehower, R. C.; Rowinsky, E. K. Development of polyploidization in taxol-resistant human leukemia cells in vitro. Cancer Res. 50:710-716; 1990.
33. Long, B. H.; Fairchild, C. R. Paclitaxel inhibits progression of mitotic cells to Gl phase by interference with spindle formation without affecting other microtubule functions during anaphaseand telophase. Cancer Res. 54:4355-4361; 1994.
34. Vaux, D. L.; Cory, S.; Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and co-operates with c-myc to immortalize pre-B cells. Nature 335:440-442; 1988.
35. Nunez, G.; Clarke, M. F. The bcl-2 family of proteins: Regulators of cell death and survival. Trends Cell Biol. 4:399-403; 1994.
36. Haldar, S.; Jena, N.; Croce, C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sei. USA 92:4507-4511; 1995.
37. Haldar, S.; Jena, N.; Croce, C. M. Anti-apoptosis potential of bcl-2 oncogene by dephosphorylation. Biochem. Cell Biol. 72:455-462; 1994.
38. Haldar, S.; Chintapalli, J.; Croce, C. M. Taxol induces bcl-2 phosphorylation and death of prostrate cancer cells. Cancer Res. 56:1253-1255:1996.
39. Ponnathpur, V.; Ibrado, A. M.; Reed, J. C.; Ray, S.; Huang, Y.; Self, S.; Bullock, G.; Nawabi, A.; Bhalla, K. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26bcl-2 protein. Clin. Cancer Res. 1:1399-1406; 1995.
40. Donaldson, K. L.; Goolsby, G.; Kiener, P. A.; Wahl, A. F. Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differen. 5:1041-1050; 1994.
41. Murray, A. W.; Kirschner, M. W. Dominoes and clocks: The union of two views of the cell cycle. Science 246:614-621; 1989.
42. Kung, A. L.; Sherwood, S. W.; Schimke, R. T. Cell linespecific differences in the control of cell cycle progression in the absence of mitosis. Proc. Natl. Acad. Sei. USA 87:95539557; 1990.
43. Woods, C. M.; Zhu, J.; McQueney, P. A.; Bollag, D.; Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1:506-526; 1995.
44. Nagasawa, H.; Li, C. Y.; Maki, C. G.; Imrich, A. C.; Little, J. B. Relationship between radiation-induced Gl phase arrest and p53 function in human tumor cells. Cancer Res. 55:18421846; 1995.
45. Wahl, A. F.; Donaldson, K. L.; Fairchild, C.; Lee, F. Y. F.; Foster, S. A.; Demers, G. \V.; Galloway, D. A. Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nature Med. 2:72-79; 1996.
46. Trielli, M. O.; Andreassen, P. R.; Lacroix, F. B.; Margolis, R. L. Differential taxol-dependent arrest of transformed and nontransformed cells in the Gl phase of the cell cycle, and specific-related mortality of transformed cells. J. Cell Biol. 135:689-700; 1996.
47. Debernardis, D.; Sire, E. G.; De Feudis, P.; Vikhanskaya, F.; Valent!, M.; Russo, P.; Parodi, S.; D'lncalci, M.; Broggini, M. p53 status does not affect sensitivity of human ovarian cancer ceil lines to paclitaxel. Cancer Res. 57:870-874; 1997.